GB201420533D0 - Use of Nanomaterials in treating cancer - Google Patents

Use of Nanomaterials in treating cancer

Info

Publication number
GB201420533D0
GB201420533D0 GBGB1420533.0A GB201420533A GB201420533D0 GB 201420533 D0 GB201420533 D0 GB 201420533D0 GB 201420533 A GB201420533 A GB 201420533A GB 201420533 D0 GB201420533 D0 GB 201420533D0
Authority
GB
United Kingdom
Prior art keywords
nanomaterials
treating cancer
cancer
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1420533.0A
Other versions
GB2532449A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manchester
Original Assignee
University of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Manchester filed Critical University of Manchester
Priority to GB1420533.0A priority Critical patent/GB2532449A/en
Publication of GB201420533D0 publication Critical patent/GB201420533D0/en
Publication of GB2532449A publication Critical patent/GB2532449A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/44Elemental carbon, e.g. charcoal, carbon black
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B32/00Carbon; Compounds thereof
    • C01B32/15Nano-sized carbon materials
    • C01B32/182Graphene
    • C01B32/184Preparation
    • C01B32/19Preparation by exfoliation
    • C01B32/192Preparation by exfoliation starting from graphitic oxides
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B32/00Carbon; Compounds thereof
    • C01B32/20Graphite
    • C01B32/21After-treatment
    • C01B32/23Oxidation
GB1420533.0A 2014-11-19 2014-11-19 Use of Nanomaterials in treating cancer Withdrawn GB2532449A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1420533.0A GB2532449A (en) 2014-11-19 2014-11-19 Use of Nanomaterials in treating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1420533.0A GB2532449A (en) 2014-11-19 2014-11-19 Use of Nanomaterials in treating cancer

Publications (2)

Publication Number Publication Date
GB201420533D0 true GB201420533D0 (en) 2014-12-31
GB2532449A GB2532449A (en) 2016-05-25

Family

ID=52248578

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1420533.0A Withdrawn GB2532449A (en) 2014-11-19 2014-11-19 Use of Nanomaterials in treating cancer

Country Status (1)

Country Link
GB (1) GB2532449A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113842788A (en) * 2021-09-22 2021-12-28 南京信息工程大学 Preparation method of hydroxylamine functionalized graphene membrane and application of hydroxylamine functionalized graphene membrane in gas-water separation

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017066583A1 (en) * 2015-10-16 2017-04-20 University Of Utah Research Foundation A nanomaterial complex comprising graphene oxide associated with a therapeutic agent and methods of use
CN106220651B (en) * 2016-07-18 2018-11-13 温州医科大学 A kind of class of anthrone containing amino oxygen functionalization graphene material and preparation method thereof and as the application prepared on antitumor drug
EP3597595A1 (en) 2018-07-17 2020-01-22 Graphenano Medical Care, S.L. Graphene product and cosmetic uses thereof
EP3597594A1 (en) 2018-07-17 2020-01-22 Graphenano Medical Care, S.L. Graphene product and therapeutic uses thereof
CN112089834B (en) * 2020-10-26 2022-11-18 北京工业大学 Preparation and application of pachyman nano adjuvant based on graphene oxide and adjuvant/antigen co-delivery vaccine
PL243445B1 (en) * 2021-08-13 2023-08-28 Gdanski Univ Medyczny GO-2-ME and rGO 2-ME hybrids, method of their preparation and application
CN114796486B (en) * 2022-03-21 2023-03-21 华南理工大学 Preparation method and application of platinum/titanium dioxide @ manganese dioxide-polyethyleneimine composite anticancer nanomaterial

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102657872B (en) * 2012-05-05 2013-11-27 上海师范大学 Multifunctional graphene oxide/ polyamide-amine (PAMAM)/ diethylene triamine pentaacetic-gadolinium (DTPA-Gd)/ prostate stem cell antigen (PSCA) antibody material and preparation method and application thereof
CN103405791B (en) * 2013-08-09 2015-11-18 上海师范大学 A kind of graphene oxide/BaGdF 5/ PEG multifunctional material and its preparation method and application
CN103483466B (en) * 2013-09-04 2015-09-23 郑州大学 A kind of preparation method of graphene oxide derivative and application

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113842788A (en) * 2021-09-22 2021-12-28 南京信息工程大学 Preparation method of hydroxylamine functionalized graphene membrane and application of hydroxylamine functionalized graphene membrane in gas-water separation
CN113842788B (en) * 2021-09-22 2023-04-21 南京信息工程大学 Preparation method of hydroxylamine functionalized graphene film and application of hydroxylamine functionalized graphene film in gas-water separation

Also Published As

Publication number Publication date
GB2532449A (en) 2016-05-25

Similar Documents

Publication Publication Date Title
IL250677A0 (en) Treatment of cancers using anti-nkg2a agents
IL251630A0 (en) Combination therapy for use in cancer therapy
IL251905B (en) Apilimod for use in the treatment of renal cancer
HUE054673T2 (en) Methods and compositions for treating cancer
IL276733A (en) Use of eribulin in the treatment of cancer
IL248767B (en) Trimethoxyphenyl-benzimidazole compound for use in the treatment of cancer
GB201420533D0 (en) Use of Nanomaterials in treating cancer
HK1231561A1 (en) Cancer treatment
HK1213817A1 (en) Methods of treating cancer
IL251903A0 (en) Apilimod for use in the treatment of colorectal cancer
HK1219513A1 (en) Methods of treating cancer
SG10202001388YA (en) Use of ureidomustine (bo-1055) in cancer treatment
GB201408297D0 (en) Treatment of cancer
GB201417456D0 (en) Treatment of cancer
GB201410695D0 (en) Uses of oligouronates in cancer treatment
GB201411111D0 (en) bis-Pyridazine compounds and their use in treating cancer
ZA201403006B (en) Composition for use in treatment of cancer
GB201418640D0 (en) Agents and methods for treatment of cancer
GB201322958D0 (en) Uses of oligouronates in cancer treatment
GB201409362D0 (en) Treatment of cancer
GB201405449D0 (en) Treatment of cancer
GB201405075D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)